Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
World Para Athletics has announced that Tashkent will host the 2027 World Para Athletics Championships.…
HDFC Life has approved the reappointment of Vibha Padalkar as the Managing Director and Chief…
Abhishek Sharma has delivered the exceptional performance and makes the new record for his century…
NASA has successfully completed the assembly of the Nancy Grace Roman Space Telescope at the…
Global rating agency Moody's has revised the India's economic outlook and cuts the FY27 GDP…
Arthur Law has been named the Young Global Leader (YGL) 2026 by the World Economic…